11. Chloramphenicol. Polymyxins. Antifolate drugs Flashcards
Chloramphenicol
Protein synthesis inhibitor S50 subunit - reversible inhibition (inhibits peptide bond formation)
Bacteriostatic depends on dose and the organism can be cidal
Spectrum: WIDE G+ive, G-ive, Anaerobes, Rickettsiae, chlamydia, Spirochetes
Administration: IV
Distribution: wide, enters CNS
Metabolism: hepatic (glucuronidation) - inhibits CYP450 (blocks metabolism of warfarin, phenytoin)
Elimination: Kidney (tubular excretion) | Breast milk
Adverse effect: Aplastic anemia, gray baby syndrome
Polymyxins
Polymyxin B Polymyxin E (colistin)
Antifolate drugs
Sulfonamides
Trimethoprim
Polymyxin E
colistin
Polymyxin B
Polymyxin E
Cation polypeptides that bind to the membrane altering permeability
Bactericidal (dose dependant)
Spectrum: G-ive, Pseudomonas (Not effective: proteus, serretia) Polymyxin E (colistin) can treat Pseudomonas (Cystic fibrosis) → given aerosol
Distribution: poor, do not enter CNS
Adverse effect: Neurotoxicity | Nephrotoxicity
adminstration of Polymyxin E & B
Polymyxin B: IV, otic, ophthalmic, topical
Polymyxin E: IV, aerosol
Sulfonamides
Sulfadoxine Sulfasalazine Sulfamethoxazole Sulfadimidine Sulfadiazine (Silver sulfadiazine)
Sulfadoxine Sulfasalazine Sulfamethoxazole Sulfadimidine Sulfadiazine (Silver sulfadiazine)
Sulfonamides
Synthetic analog of PABA
Inhibits dihydropteroate synthase (found only in bacteria)
Bacteriostatic
Spectrum: Nocardia, enteric bacteria, proteus
given with Pyrimethamine can treat - Leishmaniasis, toxoplasmosis, Pl. falciparum
Mechanism of resistance:
Overproduction of PABA
Decreased permeability
Altered dihydropteroate
Distribution: WIDE (including CSF, Placenta, urinary tract) | Binds albumin (increased activity of warfarin)
Metabolism: Acetylation (lowers solubility), glucuronidation
Excretion: Kidney (glomerular filtration) and breast milk
Adverse effect: Allergic reaction (stevens-johnson syndrome) | photosensitivity | nephrotoxicity (crystalluria) | Kernicterus | Hematotoxicity (megaloblastic anemia, hemolytic anemia in G6PD)
differences between ….
Sulfasalazine
Sulfamethoxazole
Sulfadiazine (Silver sulfadiazine)
the Administration:
Oral
Medium acting: Sulfamethoxazole, Sulfadiazine
Long acting: Sulfadoxine
Non absorbable: Sulfasalazine (for U.colitis)
Topical:
Silver sulfadiazine For burn wounds
Trimethoprim
Inhibits dihydrofolate reductase (found also in human)
Adverse effect: Folic acid deficiency
Monotherapy → rapid resistance
For UTI’s
usually given in combination (synergic) with → Cotrimoxazole
Cotrimoxazole
Sulfamethoxazole + Trimethoprim
has synergic effect
Bactericidal
Use: Pneumocystis jiroveci, toxoplasmosis, nocardiosis, resistance salmonella, UTI.
Adverse effect: Skin rash, hepatotoxicity, Nausea